Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy
Sponsor: Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS
Terminated
STOP due to recent data in literature questioning the need to continue DAP beyond six months in patients with stable coronary artery stenting with DES.
Other Angina Pectoris trials with similar outcome
Listed as NCT00944333, this PHASE3 trial focuses on Angina Pectoris and Silent Ischemia and remains terminated or withdrawn. Sponsored by Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS, it has been updated 10 times since 2009, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE3
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated PHASE3
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE3
-
Feb 2018 — May 2018 [monthly]
Terminated PHASE3
-
Aug 2017 — Feb 2018 [monthly]
Terminated PHASE3
-
Jan 2017 — Aug 2017 [monthly]
Terminated PHASE3
First recorded
Jul 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS
For direct contact, visit the study record on ClinicalTrials.gov .